CaMKII as a therapeutic target in cardiovascular disease
OE Reyes Gaido, LJ Nkashama… - Annual review of …, 2023 - annualreviews.org
CaMKII (the multifunctional Ca2+ and calmodulin-dependent protein kinase II) is a highly
validated signal for promoting a variety of common diseases, particularly in the …
validated signal for promoting a variety of common diseases, particularly in the …
Emerging antiarrhythmic drugs for atrial fibrillation
Atrial fibrillation (AF), the most common cardiac arrhythmia worldwide, is driven by complex
mechanisms that differ between subgroups of patients. This complexity is apparent from the …
mechanisms that differ between subgroups of patients. This complexity is apparent from the …
Novel CaMKII-δ inhibitor hesperadin exerts dual functions to ameliorate cardiac ischemia/reperfusion injury and inhibit tumor growth
Background: Cardiac ischemia/reperfusion (I/R) injury has emerged as an important
therapeutic target for ischemic heart disease, the leading cause of morbidity and mortality …
therapeutic target for ischemic heart disease, the leading cause of morbidity and mortality …
[HTML][HTML] Atrial fibrillation: epigenetic aspects and role of sodium-glucose cotransporter 2 inhibitors
M Donniacuo, A De Angelis, M Telesca… - Pharmacological …, 2023 - Elsevier
Atrial fibrillation (AF) is the most frequent arrhythmia and is associated with substantial
morbidity and mortality. Pathophysiological aspects consist in the activation of pro-fibrotic …
morbidity and mortality. Pathophysiological aspects consist in the activation of pro-fibrotic …
Gene editing in common cardiovascular diseases
AM Lauerer, XM Caravia, LS Maier, F Chemello… - Pharmacology & …, 2024 - Elsevier
Cardiovascular diseases are the leading cause of morbidity and mortality worldwide,
highlighting the high socioeconomic impact. Current treatment strategies like compound …
highlighting the high socioeconomic impact. Current treatment strategies like compound …
Experimental drugs for supraventricular tachycardia: an analysis of early phase clinical trials
Introduction Supraventricular tachycardias (SVT) are a diverse group of commonly
encountered arrhythmias arising at or above the atrioventricular (AV) node. Conventional …
encountered arrhythmias arising at or above the atrioventricular (AV) node. Conventional …
Elimination of CaMKIIδ Autophosphorylation by CRISPR-Cas9 base editing improves survival and cardiac function in heart failure in mice
S Lebek, XM Caravia, F Chemello, W Tan… - Circulation, 2023 - Am Heart Assoc
BACKGROUND: Cardiovascular diseases are the main cause of worldwide morbidity and
mortality, highlighting the need for new therapeutic strategies. Autophosphorylation and …
mortality, highlighting the need for new therapeutic strategies. Autophosphorylation and …
Loss of CASK accelerates heart failure development
J Mustroph, CM Sag, F Bähr, AL Schmidtmann… - Circulation …, 2021 - Am Heart Assoc
Rationale: Increased myocardial activity of CaMKII (Ca/calmodulin-dependent kinase II)
leads to heart failure and arrhythmias. In Drosophila neurons, interaction of CaMKII with …
leads to heart failure and arrhythmias. In Drosophila neurons, interaction of CaMKII with …
CaMKII in regulation of cell death during myocardial reperfusion injury
Y Yang, K Jiang, X Liu, M Qin, Y **ang - Frontiers in Molecular …, 2021 - frontiersin.org
Cardiovascular disease is the leading cause of death worldwide. In spite of the mature
managements of myocardial infarction (MI), post-MI reperfusion (I/R) injury results in high …
managements of myocardial infarction (MI), post-MI reperfusion (I/R) injury results in high …
CaMKII,'jack of all trades' in inflammation during cardiac ischemia/reperfusion injury
W Zhang, E Dong, J Zhang, Y Zhang - Journal of Molecular and Cellular …, 2023 - Elsevier
Myocardial infarction and revascularization cause cardiac ischemia/reperfusion (I/R) injury
featuring cardiomyocyte death and inflammation. The Ca 2+/calmodulin dependent protein …
featuring cardiomyocyte death and inflammation. The Ca 2+/calmodulin dependent protein …